Experience

Jiawei Zhou earned his PhD from the Imperial College, UK in 1996. He received his postdoctoral training in the Hahnemann University, USA in 1996-1998, and was appointed as a Laboratory Head of the Shanghai Institute of Physiology in 1998. He is currently a Senior Investigator in the Institute of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences. His research focus on the molecular and cellular mechanisms underlying the maintenance of immune homeostasis in the CNS and the regulation of dopaminergic neurotransmission in mammals. Specific focuses are in understanding cell signaling that regulates neuroinflammation in Parkinson’s disease (Nature, 2013; PNAS, 2023), multiple sclerosis (J Exp Med, 2022, Immunity, 2023), as well as molecular basis for dopamine storage and reuptake (Nat Neurosci, 2015). His group discovered GFRAL gene (J Neurochem, 2005), laying the foundation for understanding of central control of weight and food intake mediated by its ligand GDF15. He is the recipient of several awards, including the Outstanding Youth Award (NSFC), Sanofi Neuroscience Outstanding Scholarship Award. He currently serves as the Vice President of the Chinese Association for Physiological Sciences (CAPS), the head of the neurodegenerative disease research subcommittee, Chinese Neuroscience Society. He is a member of editorial board of several scientific journals, such as Transl Neurodegener, Neurosci Bull.